WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016094402) TREATMENT OF BREAST CANCER WITH LIPOSOMAL IRINOTECAN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/094402    International Application No.:    PCT/US2015/064491
Publication Date: 16.06.2016 International Filing Date: 08.12.2015
IPC:
A61K 31/436 (2006.01), A61K 9/127 (2006.01), A61K 35/04 (2006.01)
Applicants: IPSEN BIOPHARM LTD. [US/US]; Ash Road, Wrexham Industrial Estate Wrexham, GB LL13 9UF (US)
Inventors: BAYEVER, Eliel; (US).
FITZGERALD, Jonathan, Basil; (US).
KIM, Jaeyeon; (US).
KLINZ, Stephan; (US)
Agent: BOTT, Cynthia, M.; (US)
Priority Data:
62/089,685 09.12.2014 US
Title (EN) TREATMENT OF BREAST CANCER WITH LIPOSOMAL IRINOTECAN
(FR) TRAITEMENT DU CANCER DU SEIN À L'AIDE D'IRINOTÉCAN LIPOSOMAL
Abstract: front page image
(EN)Provided are methods for treating breast cancer in a patient by administering effective amounts of liposomal irinotecan sucrosofate (MM-398). The breast cancer may be triple negative breast cancer (TNBC), estrogen receptor/progesterone receptor (ER/PR) positive breast cancer, ER-positive breast cancer, or PR-positive breast cancer, or metastatic breast cancer.
(FR)L'invention concerne des méthodes de traitement du cancer du sein chez un patient par administration de quantités efficaces d'irinotécan sucrosofate liposomal (MM-398). Le cancer du sein peut être un cancer du sein triple négatif (TNBC), un cancer du sein positif au récepteur des oestrogènes/récepteur de la progestérone (ER/PR), un cancer du sein ER-positif, ou PR-positif, ou un cancer du sein métastatique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)